Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 161 - 170 of 231 for CRO. (0.06 seconds)

CBT 200 Scores A Win. More details...
CBT 200 Takes a 46 Point Tumble. More details...
CBT 200 Tumbles 40 Points. More details...
Company Seeks $324 Million Market Cap. More details...
CBT 200 Climbs 4%. More details...
CBT 200 Rises 16 Points. More details...
Blockbuster Drug Extends Its Reach. More details...
CBT 200 Little Changed With 12 Point Rise. More details...
Exclusive Right To GeneMap of Complex Disease. More...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here